Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,227,732
+$12,457,743 QoQ
Shares Held
292,614
+76.1% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#37
of 282 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Jun 30, 2026CallValue
$204,710
CallShares
2,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. BNTX ranks #45 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in BNTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,710 | 2,200 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $27,227,732 | 292,614 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,769,989 | 166,179 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,306,161 | 108,258 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $936,435 | 11,653 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $232,188 | 2,200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $901,712 | 8,300 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $895,819 | 8,300 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $1,397,046 | 9,300 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $11,704,120 | 45,400 | Call | Sole | 2022-02-14 | |
| 2021-12-31 | $8,971,440 | 34,800 | Put | Sole | 2022-02-14 | |
| 2021-09-30 | $10,018,733 | 36,700 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $15,787,284 | 57,831 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $5,896,584 | 21,600 | Put | Sole | 2021-11-15 | |
| 2021-06-30 | $3,134,320 | 14,000 | Call | Sole | 2021-08-16 | |
| 2021-06-30 | $3,201,484 | 14,300 | Put | Sole | 2021-08-16 | |
| 2021-06-30 | $62,310,953 | 278,323 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $9,915,685 | 121,635 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||